November 2015

BioSyent Inc. ("BioSyent") announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of CYSVIEW®, a new photosensitizer for the detection and management of papillary Non-Muscle Invasive Bladder Cancer (NMIBC).

The sex-enhancing drug Viagra may help people at risk for diabetes by improving insulin sensitivity in them, a first-of-its-kind study has revealed.

A fresh clinical trial of a new Ebola vaccine has found that it is well tolerated, safe and stimulates strong immune responses in adults in Mali, West Africa and in the US.

The Union Minister of Chemicals and Fertilizers Shri Ananth Kumar has announced the setting up of National Institute of Pharmaceutical Education and Research (NIPER) in Jhalawar, Rajasthan. Speaking at the Resurgent Rajasthan function in Jaipur today, he said that the Government will invest Rs 500 crore in this international level institute which will come up in two years.

The Union Cabinet, chaired by Prime Minister Narendra Modi has approved the proposal of the Department of Health Research in the Ministry of Health and Family Welfare for setting up of a National Resource Facility for Bio-medical Research (NARF) at Genome Valley in Hyderabad by the Indian Council for Medical Research (ICMR).

The merger of the world's two largest beer manufacturers represents a major threat to global health, warn health experts, adding that the funders and regulators must respond more effectively to this threat. Last month, Belgium-based Anheuser-Busch InBev (AB InBev) and London-based SABMiller agreed in principle to merge.

Low levels of vitamin D may limit immune recovery in HIV-positive adults undergoing treatment, says a new study. Those infected with HIV often struggle with declining health because their immune systems can not effectively respond to common pathogens.